emptyone This is a good explanation I think for the high market value: "No different than any other R&D company emerging into commercialization with an industry changing patent. Emerging R&D companies are front end loaded as the fundamentals will catch up with the valuation. Imagine there are some that refused to buy at .01 waiting for fundamentals to improve - you have to be prescient at this level to make $$$. R&D companies do not trade on fundamentals nor does their valuation come from fundamentals - the valuation comes from potential earnings."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.